Intuitive Surgical Inc . (NASDAQ:ISRG) Executive Vice President and Chief Strategy & Corporate Operations Officer, Robert DeSantis, has recently engaged in significant trading of company shares, according to a new SEC filing. DeSantis sold shares totaling over $695,000, with prices ranging from $368.1 to $375.39.
The transactions took place on April 26 and April 29, as part of a trading plan that complies with SEC Rule 10b5-1, which allows insiders to set up a predetermined plan to sell stocks at a time when they are not in possession of material non-public information. This plan is set to expire on December 9, 2024.
On April 26, DeSantis disposed of 188 shares at $368.1 each and another 396 shares at $375.0 each. On the same day, he also sold 396 shares at $368.1 each, followed by 90 shares at the same price. He continued the selling spree on April 29 with 188 shares at $375.39 each and concluded with another batch of 188 shares at the same price.
In addition to the sales, DeSantis also acquired shares through exercising options, with the total value of these transactions reaching approximately $502,805. The prices for these option exercises varied, with the lowest at $179.7 and the highest at $347.4167.
The filing indicates that DeSantis's transactions were executed in direct ownership form, and after the reported sales and option exercises, he still maintains a significant number of shares in Intuitive Surgical.
Investors and market watchers often look to insider trading behaviors such as these to gain insights into a company's performance and executive sentiment. Intuitive Surgical, known for its da Vinci surgical systems, remains a key player in the field of robotic-assisted surgery.
For detailed figures and transactions, investors can refer to the full SEC Form 4 filing.
InvestingPro Insights
As Intuitive Surgical Inc. (NASDAQ:ISRG) sees activity from its executive vice president, Robert DeSantis, the company's financial metrics provide context to the stock's recent performance. The company sports a robust market capitalization of $132.43 billion, underscoring its significant presence in the medical technology sector. With a Price/Earnings (P/E) ratio sitting at 65.9, the company is trading at a high earnings multiple, which is a point of interest for those scrutinizing valuation metrics. This high P/E ratio is further emphasized when looking at the last twelve months as of Q1 2024, which shows a slightly adjusted P/E of 66.35.
Intuitive Surgical's stock has also experienced a substantial price uptick over the last six months, with a 42.68% return, reflecting a strong market performance that investors may find encouraging. Additionally, the company's solid revenue growth of 13.81% over the last twelve months signals a healthy expansion in its business operations.
InvestingPro Tips suggest that while Intuitive Surgical is trading at a high P/E ratio relative to near-term earnings growth, the stock generally trades with low price volatility, which could be a sign of stability for interested investors. Moreover, for those seeking more in-depth analysis, there are additional InvestingPro Tips available, including insights on the company's profitability and valuation multiples. Interested readers can explore these further by visiting the company's specific page on Investing.com/pro/ISRG.
For those considering a deeper dive into Intuitive Surgical's financial health, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro, where you can access a total of 14 InvestingPro Tips that could inform your investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.